Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Sleep Initiation and Maintenance Disorders 2Neoplasms 2Lymphoma 2Glioma 2Glioblastoma 2Uterine Neoplasms 1Sleep Wake Disorders 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Oligodendroglioma 1Nervous System Diseases 1Multiple Myeloma 1Meningioma 1Lung Neoplasms 1Leukemia 1Fatigue 1Esophageal Neoplasms 1Depression 1Brain Neoplasms 1Astrocytoma 1Anxiety Disorders 1

Interventions

XENP 1595 2Oncolytic Virotherapy 2Cancer Vaccines 2Adjuvants, Immunologic 2pembrolizumab 1pamiparib 1interferon gamma-1b 1glutathione pegylated liposomal doxorubicin 1Trastuzumab 1Radiation 1Interferon-gamma 1Immunotherapy 1Cognitive Behavioral Therapy 1Clinical Laboratory Techniques 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nervous System Diseases × Cognitive Behavioral Therapy × CNS × Clear all
NCT06468176 2025-12-19

FREEDOME

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting
187 enrolled
CNS

Glioma, Neoplasms, Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡